These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 14571255)

  • 1. Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease.
    Garcia-Alloza M; Hirst WD; Chen CP; Lasheras B; Francis PT; Ramírez MJ
    Neuropsychopharmacology; 2004 Feb; 29(2):410-6. PubMed ID: 14571255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.
    Garcia-Alloza M; Gil-Bea FJ; Diez-Ariza M; Chen CP; Francis PT; Lasheras B; Ramirez MJ
    Neuropsychologia; 2005; 43(3):442-9. PubMed ID: 15707619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease.
    Lai MK; Tsang SW; Alder JT; Keene J; Hope T; Esiri MM; Francis PT; Chen CP
    Psychopharmacology (Berl); 2005 May; 179(3):673-7. PubMed ID: 15551121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]GR113808 binding to serotonin 5-HT(4) receptors in the postmortem neocortex of Alzheimer disease: a clinicopathological study.
    Lai MK; Tsang SW; Francis PT; Esiri MM; Hope T; Lai OF; Spence I; Chen CP
    J Neural Transm (Vienna); 2003 Jul; 110(7):779-88. PubMed ID: 12811638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.
    Aisa B; Gil-Bea FJ; Solas M; García-Alloza M; Chen CP; Lai MK; Francis PT; Ramírez MJ
    J Alzheimers Dis; 2010; 20(2):659-68. PubMed ID: 20164549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
    DeKosky ST; Ikonomovic MD; Styren SD; Beckett L; Wisniewski S; Bennett DA; Cochran EJ; Kordower JH; Mufson EJ
    Ann Neurol; 2002 Feb; 51(2):145-55. PubMed ID: 11835370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease.
    Garcia-Alloza M; Tsang SW; Gil-Bea FJ; Francis PT; Lai MK; Marcos B; Chen CP; Ramirez MJ
    Neurobiol Aging; 2006 Aug; 27(8):1110-7. PubMed ID: 15996794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease.
    Lai MK; Tsang SW; Francis PT; Esiri MM; Keene J; Hope T; Chen CP
    Brain Res; 2003 Jun; 974(1-2):82-7. PubMed ID: 12742626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.
    Benhamú B; Martín-Fontecha M; Vázquez-Villa H; Pardo L; López-Rodríguez ML
    J Med Chem; 2014 Sep; 57(17):7160-81. PubMed ID: 24850589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
    Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
    Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT(7) receptors in the modulation of cognitive processes.
    Cifariello A; Pompili A; Gasbarri A
    Behav Brain Res; 2008 Dec; 195(1):171-9. PubMed ID: 18243350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of an altered 5-HT -{6} receptor function in behavioral symptoms of Alzheimer's disease.
    Marcos B; García-Alloza M; Gil-Bea FJ; Chuang TT; Francis PT; Chen CP; Tsang SW; Lai MK; Ramirez MJ
    J Alzheimers Dis; 2008 May; 14(1):43-50. PubMed ID: 18525126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.
    Bowen DM; Procter AW; Mann DM; Snowden JS; Esiri MM; Neary D; Francis PT
    Psychopharmacology (Berl); 2008 Mar; 196(4):603-10. PubMed ID: 18026720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous serotonin facilitates in vivo acetylcholine release in rat frontal cortex through 5-HT 1B receptors.
    Consolo S; Arnaboldi S; Ramponi S; Nannini L; Ladinsky H; Baldi G
    J Pharmacol Exp Ther; 1996 May; 277(2):823-30. PubMed ID: 8627564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
    Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
    Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease.
    Lai MK; Tsang SW; Francis PT; Keene J; Hope T; Esiri MM; Spence I; Chen CP
    Neuroreport; 2002 Jul; 13(9):1175-8. PubMed ID: 12151764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1B receptors and aggression: a review.
    Olivier B; van Oorschot R
    Eur J Pharmacol; 2005 Dec; 526(1-3):207-17. PubMed ID: 16310769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GR127935-sensitive 5-HT(1) receptors mediating canine internal carotid vasoconstriction: resemblance to the 5-HT(1B), but not to the 5-HT(1D) or 5-ht(1F), receptor subtype.
    Centurión D; Sánchez-López A; De Vries P; Saxena PR; Villalón CM
    Br J Pharmacol; 2001 Mar; 132(5):991-8. PubMed ID: 11226129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-β load and cognitive decline in Alzheimer's disease.
    Morawski M; Schilling S; Kreuzberger M; Waniek A; Jäger C; Koch B; Cynis H; Kehlen A; Arendt T; Hartlage-Rübsamen M; Demuth HU; Roßner S
    J Alzheimers Dis; 2014; 39(2):385-400. PubMed ID: 24164736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.